FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • January 6th, 2020 • Medicines Co /De • Pharmaceutical preparations • New York
Contract Type FiledJanuary 6th, 2020 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE, dated as of January 6, 2020 (this “Supplemental Indenture”), by and between THE MEDICINES COMPANY, a Delaware corporation, as issuer (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee (the “Trustee”), supplements the Indenture, dated as of December 18, 2018 (the “Indenture”), between the Company and the Trustee.
FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • January 6th, 2020 • Medicines Co /De • Pharmaceutical preparations • New York
Contract Type FiledJanuary 6th, 2020 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE, dated as of January 6, 2020 (this “Supplemental Indenture”), by and between THE MEDICINES COMPANY, a Delaware corporation, as issuer (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee (the “Trustee”), supplements the Indenture, dated as of January 13, 2015 (the “Indenture”), between the Company and the Trustee.
FIRST SUPPLEMENTAL INDENTUREFirst Supplemental Indenture • January 6th, 2020 • Medicines Co /De • Pharmaceutical preparations • New York
Contract Type FiledJanuary 6th, 2020 Company Industry JurisdictionFIRST SUPPLEMENTAL INDENTURE, dated as of January 6, 2020 (this “Supplemental Indenture”), by and between THE MEDICINES COMPANY, a Delaware corporation, as issuer (the “Company”), and WELLS FARGO BANK, NATIONAL ASSOCIATION, as trustee (the “Trustee”), supplements the Indenture, dated as of June 10, 2016 (the “Indenture”), between the Company and the Trustee.